European Reference Networks: strategic value for the Member States. Perspective of France

Similar documents
European Reference Networks. Guidance on the recognition of Healthcare Providers and UK Oversight of Applications

EUCERD RECOMMENDATIONS QUALITY CRITERIA FOR CENTRES OF EXPERTISE FOR RARE DISEASES IN MEMBER STATES

UNION EUROPÉENNE DES MÉDECINS SPÉCIALISTES

EUCERD RECOMMENDATIONS on RARE DISEASE EUROPEAN REFERENCE NETWORKS (RD ERNS)

European Reference Networks (ERN) Guide for patient advocates

ERN Assessment Manual for Applicants

2ème Conférence sur les Réseaux Européens de Référence. 8-9 octobre 2015, Lisbonne. Table ronde ministérielle (8 octobre 12 :15 13 :00)

ERN IT Platform delivering the virtual link for the Networks

Member webinar: What is an ideal European Reference Network? Matt Johnson, EURORDIS 10 February 2016

2nd European Reference Networks Conference 8-9 October Lisbon, Portugal. A report by: G Porto & F Courtois

European Haemophilia Consortium

National Plans for Rare Diseases The French plan Ségolène Aymé Orphanet On behalf of Alexandra Fourcade French Ministry of Health

Developing a European Registry for Rare Anaemias

ERN board of Member States

ERN Assessment Manual for Applicants 2. Technical Toolbox for Applicants

Background paper. Cross-border healthcare in the EU

Department of Medical Genetics, Medical School, University of Athens, Greece

WORK PLAN 2017 LAURENCE BALLIEUX NATIONAL FOCAL POINT. 1 EU 3rd HEALTH PROGRAMME

ERN The way forward: The Member States perspective

VASCERN 1st Annual Seminar Paris, France October 2017

Erasmus+ DG EAC Consultation CPU Recommendations. An integrated, targeted, long-term approach to strengthen institutional strategy

VSOP, Lupus Netherlands

EUCERD Joint Action WP7 Workshop From Centres of Expertise for Rare Diseases to European Reference Networks

Hospital Carlos Haya. Malaga, Spain

National Center for Tumor Diseases (NCT) Heidelberg, Germany

1. Have you or a member of your family had first-hand experience of an adverse event or experienced harm in a healthcare setting in your country?

Erasmus+: Youth Cyprus National Agency

The Centre for Disease Prevention and Control, Latvia

1. Have you or a member of your family had first-hand experience of an adverse event or experienced harm in a healthcare setting in your country?

Ministry for Health, the Elderly and Community Care, Malta

1. The Working Party on Public Health discussed and agreed the draft Council conclusions as set out in the Annex.

BELGIAN EU PRESIDENCY CONFERENCE ON RHEUMATIC AND MUSCULOSKELETAL DISEASES (RMD)

Central Manchester University Hospitals NHS Foundation Trust, UK

European Society of Cardiology, France

1. Have you or a member of your family had first-hand experience of an adverse event or experienced harm in a healthcare setting in your country?

SERVICIO DE NEUROCIRUGÍA PEDIÁTRICA. HOSPITAL UNIVERSITARIO 12 DE OCTUBRE, Spain

RED CELL PATHOLOGY UNIT. HOSPITAL CLINIC-UNIVERSITY OF BARCELONA, Spain

Morbidity statistics in the EU

G-I-N 2016 conference report

Mississauga Halton Local Health Integration Network (LHIN) Francophone Community Consultation - May 9, 2009

Riga East University hospital stationary Infectology Center of Latvia (RAKUS LIC), Latvia

EU Health Programmes

The INTERREG IVC approach to capitalise on knowledge

Brussels, 10 November 2003 COUNCIL THE EUROPEAN UNION 14487/03 TELECOM 144. REPORT from : COREPER date : 7 November 2003

Jean Monnet Activities in Slovakia

Hospital Universitario de Getafe (Getafe Universitary Hospital), Spain

Medical devices briefing for patients: Patient safety in the new Regulation

Erasmus MC, Center for lysosomal and metabolic diseases, Netherlands

Cystic Fibrosis Europe (CFE), Germany

November Dimitri CORPAKIS Head of Unit Research and Innovation DG Research and Innovation European Commission

Proposal for a new legal framework for data protection in EU

DISCLOSURE HOSPITAL ACCREDITATION: AIM OR MEANS. No Conflict of interest to declare PAUL VAN OSTENBERG, DDS, MS

FRENCH INSTITUTE FOR PUBLIC HEALTH SURVEILLANCE

116 Help Lines for Rare Diseases

DRAFT OPINION. EN United in diversity EN. European Parliament 2018/0018(COD) of the Committee on Industry, Research and Energy

Cross Border Health: ERN-EuroBloodNet s overview for reaching equal access to care across EU MS

Canadian Major Trauma Cohort Research Program

INSTITUTE OF CHILD HEALTH, Greece

Spreading Excellence and Widening Participation in Horizon 2020

Delegations will find below the above-mentioned Council conclusions, as endorsed by the Council (General Affairs) on 14 September 2015.

Scandinavian Ear Reconstruction Centre, Dept of Plastic and Reconstructive Surgery, SWEDEN

RESEARCH PROJECT GRANTS 2017

Draft mandate Morbidity and Mortality Working Party

biopsie chez l enfant

Improving care for patients with chronic and complex care needs

Radboud University Nijmegen Medical Centre, department of Neurology, Netherlands

EUROPEAN COMMISSION DIRECTORATE-GENERAL FOR HEALTH AND FOOD SAFETY

Supportive Care Roundtable

Newborn bloodspot screening

Electronic Health Records for research and Hospital management. The "Assistance Publique - Hôpitaux de Paris" initiative

THE BETTER ENTREPRENEURSHIP POLICY TOOL

Different dimensions of the ONCE-ONLY principle

Continuous Professional Development of Health Professionals European Context

Improving patients rights

The implementation of the Clinical Trial Regulation (CTR, n 536/2014) in Belgium. and impact on the ethical review process

COMMISSION OF THE EUROPEAN COMMUNITIES

Memorandum of understanding for shadow Accountable Care Systems

Oxford Cambridge and RSA

CONSULTANT PAEDIATRIC HISTOPATHOLOGIST. 21 hours Temple Street Children s University Hospital 18 hours Our Lady s Children s Hospital, Crumlin

ERN-EYE Kick-Off Meeting brief report

EUROPEAN JOINT PROGRAMME ON RARE DISEASES

EPF Workshops on Cross-Border Healthcare 1st Stop: Croatia Meeting Report

Castilla y leon Regional Health Service (Gerencia Regional de Salud de Castilla y León)

Building the Europe of Knowledge

Annual Work Programme 2018

MS Nurse PROfessional

Global Diversity: Equity and Access

Introduction to ibmg. Marco Varkevisser Director of Education

National Strategies & Action for Rare Diseases in Europe

ANNEX I TO VIII ANNEX I. Health Programme Work Programme for 2017

Zagreb Charter. on Lifelong Entrepreneurial Learning: A Keystone for Competitiveness, Smart and Inclusive Growth and Jobs in the SEECP Participants

Document: Report on the work of the High Level Group in 2006

Council of the European Union Brussels, 8 September 2014 (OR. en) Mr Uwe CORSEPIUS, Secretary-General of the Council of the European Union

Rules of the DesignEuropa Awards. Industry and small/ emerging companies categories Lifetime Achievement category

Interreg Europe. National Info Day 26 May 2015, Helsinki. Elena Ferrario Project Officer Interreg Europe Secretariat

EUROPEAN COMMISSION HEALTH AND FOOD SAFETY DIRECTORATE-GENERAL. Flash report from the meetings with the transport, tourism and health

Rules of the DesignEuropa Awards. Industry and small/ emerging companies categories Lifetime Achievement category

Health Economics: Pharmaco-economic studies

Presenter Biographies

Patient Registry Initiative- Strategy and Mandate of the Cross-Committee Task Force

Transcription:

European Reference Networks: strategic value for the Member States Perspective of France Patrice Dosquet, MD Ministry of Health, France

2 European Reference Networks: Networks of healthcare providers/centres of expertise Improving access to highly specialised healthcare for patients/conditions requiring a particular concentration of expertise Rare, or low prevalence, and complex diseases Rarety : diseases/patients; experts; facilities/technical supports Complexity : diagnosis or treatment or management and high cost of the treatment and resources involved Multidisciplinary approach and well-planned organisation of services Patient-centred, Informed consent, Rights of the patients Any group of at least 10 healthcare providers established in at least 8 MSs

3 Roles of MSs? Nomination of centres of expertise (CEs) Information of CEs about the procedure of ERN creation and the future public call for interest Fostering participation of existing CEs to ERNs (to ERN proposals and later to existing ERNs): however, the participation of CEs is voluntary Endorsement of each CE applicant to a ERN proposal before its submission to DG SANTE : the participation if the CE is in accordance with the MS national legislation regarding licensing, accreditation, commissioning, and certification.

4 Roles of MBs? Nomination of centres of expertise: French organisation Rare diseases: During the 1st National Plan for RDs (2005-2008): 133 «centres de référence maladies rares» (CRMR), in fact 380 sites in Academic Hospitals 501 «centre de compétences maladies rares» (CCMR) During the 2 nd National Plan for RDs (2011-2016): 23 «filières de santé maladies rares» (FSMR): national networks (115 out of 133 CRMR) Rare cancer in adults: During the 2 nd National Plan for Cancer (2009-2013): 22 National Networks 4 National Anatomo-pathological Networks

Network «ANDDI-Rares»: «Developmental abnormalities, malformative syndromes & intellectual disabilities»

7 Roles of MBs? Fostering participation of CEs to ERNs: French experience Information of CEs: FSMRs, Réseaux cancers rares Many issues at the moment: - How to identify healthcare providers/ces in EU aiming to build a common proposal? - ERNs for healthcare or for research? - Practical consequences for the patients/their families? - Grouping of diseases in ERNs: relevance? - Roles of members and coordinator in ERNs? - Participation or coordination? - Extra workload due to ERN? - Availability of the ERN evaluation manual and tools? - Availability for the call of interest, procedure and calendar? - Fundings and practical tools? -. Endorsement of each CE for application : work in progress within MoH/INCa

8 Why to participate to ERNs? Each ERN must have at least 3 of the following 8 objectives (Art. 12): European cooperation : innovations in medical science and health technologies Pooling of knowledge regarding sickness prevention Improvements in diagnosis and the delivery of high-quality, accessible and cost-effective healthcare when expertise is rare Maximising the cost-effective use of resources by concentrating Reinforcing research, epidemiological surveillance like registries and providing training for health professionals /

9 / Facilitating mobility of expertise, virtually or physically, and developing, sharing and spreading information, knowledge and best practice and fostering developments of the diagnosis and treatment of rare diseases, within and outside the networks Encouraging the development of quality and safety benchmarks and helping develop and spread best practice within and outside the network; Help for MSs with an insufficient number of patients with a particular medical condition or lacking technology or expertise to provide highly specialised services of high quality.

10 ERNs: expectations and challenges Improvement of diagnosis, treatment and research thanks to the extension of the number of patients and sharing expertise (supply and demand) Common best practices and improvement of quality of care in EU Improvement of equity in healthcare in EU E-health Still many challenges and many questions! Pioneering spirit!

Thank you for your attention